Clinical Trials Logo

Infarction clinical trials

View clinical trials related to Infarction.

Filter by:

NCT ID: NCT04955054 Recruiting - Clinical trials for Acute Myocardial Infarction

the Association of Intestinal Microbial Metabolites and Cardiac Function in Acute Myocardial Infarction

Start date: October 11, 2020
Phase:
Study type: Observational

Recently, more and more studies have confirmed that intestinal flora is closely related to the occurrence and development of cardiovascular diseases.Bile acids (BAS), short chain fatty acids (SCFA) and trimethylamine oxide (TMAO), the main metabolites of intestinal flora, are the key mediators of the interaction between gut and host. We aim to explore the association of BAs and SCFA with cardiac function in patients with AMI.

NCT ID: NCT04952740 Completed - Clinical trials for Acute Myocardial Infarction

Application of Index of Microcirculatory Resistance to Evaluate Myocardial Protection After Ischemic Adaptation

Start date: January 1, 2014
Phase: N/A
Study type: Interventional

To evaluate the protective effect of IPC on the myocardial microcirculation response through IMR and the predictive value of IMR on the degree of myocardial reperfusion and the prognosis of patients.

NCT ID: NCT04952259 Not yet recruiting - Clinical trials for Acute Myocardial Infarction

Effect of Shexiang Tongxin Dropping Pills on Microcirculation in Patients With AMI

Start date: August 1, 2021
Phase: Phase 4
Study type: Interventional

This study is a randomized, controlled clinical trial. Evaluation of microcirculation resistance by index of microcirculation resistance to explore the protective effect of Shexiang Tongxin dripping pills on microcirculation in patients with acute anterior myocardial infarction.

NCT ID: NCT04951856 Recruiting - Clinical trials for STEMI - ST Elevation Myocardial Infarction

Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI

AMUNDSEN
Start date: September 29, 2021
Phase: Phase 4
Study type: Interventional

AMUNDSEN-real is a phase IV, international (7 European countries), multicenter, controlled, open label study randomized, in 2 parallel groups of patients with a diagnosis of STEMI or NSTEMI with an indication for PCI, using the PROBE study design (Prospective Randomised Open, Blinded Endpoint). The objective of this study is to demonstrate the superiority of evolocumab versus standard of care in reaching a LDL-C reduction of ≥ 50% from baseline and a LDL-C goal of <1.4 mmol/L (<55 mg/dL) at 12 months follow-up on the overall population. Central randomization uses an IWRS. Stratification is by center and stratum with random block size, generated according to the procedures of the sponsor, by a statistician not involved in the study.

NCT ID: NCT04950972 Recruiting - Clinical trials for Large Hemispheric Infarction (LHI)

Intravenous Administration of BIIB093 (Glibenclamide) in the Treatment of Severe Cerebral Edema After Massive Cerebral Infarction

Start date: September 1, 2020
Phase: Phase 3
Study type: Interventional

The current study is to assess efficacy and safety of intravenous (IV) BIIB093 to improve functional outcomes in subjects with LHI.

NCT ID: NCT04949906 Completed - Cerebral Infarction Clinical Trials

Study on Yangxue Nao Granules Reducing the Risk of Stroke

Start date: June 1, 2019
Phase:
Study type: Observational

Objective: To explore the effectiveness of raising serum nao granules in reducing the risk of bleeding in patients with acute ischemic stroke treated with intravenous thrombolysis in the real world

NCT ID: NCT04945122 Recruiting - Clinical trials for Acute Myocardial Infarction

Comparison of Atorvastatin and Pitavastatin on the Effect of HbA1c in AMI Patients With Abnormal Glucose Metabolism

CAPE-AMI
Start date: October 1, 2015
Phase: Phase 4
Study type: Interventional

Different types of statins show different influences on glycometabolism. There are no systemic analyses of the effects that statins exert on the metabolism of glucoses so far in China. This research aims to compare impacts on the glycometabolism of pitavastatin in AMI patients with atorvastatin and to accumulate data for guiding the utilization of statins.

NCT ID: NCT04942977 Completed - Angina, Unstable Clinical Trials

Rehabilitation After Acute Coronary Syndrome: a New Telemonitoring Strategy

Start date: May 28, 2019
Phase: N/A
Study type: Interventional

Cardiac rehabilitation after an acute coronary syndrome is recognised in the latest guidelines and recommendations published by the major scientific societies as a class I indication. Despite this evidence, the number of patients entering such programmes in Europe is still around 30%. The present study aims to validate a new comprehensive Telerehabilitation System to provide support for cardiac rehabilitation, to optimize it and to test its usefulness in terms of improving adherence to physical exercise and cardiovascular risk parameters.

NCT ID: NCT04941638 Completed - Clinical trials for ST Elevation Myocardial Infarction

Comparison of Vascular Access in STEMI

Start date: June 17, 2021
Phase:
Study type: Observational

Distal radial access (DRA) has recently introduced and previous studies have demonstrated that it is feasible option, showing several advantages including less bleeding and access-site complications over proximal radial access (PRA). Previous study reported the feasibility of DRA as an alternative option for primary percutaneous coronary intervention (PCI) in STEMI patients without major complication. However, comparison study of each vascular access for primary PCI have not been conducted until now. Here, The investigators aim to compare the DRA, PRA and femoral access (FA), in terms of feasibility and safety, in patients with STEMI. This is a retrospective study with patients who underwent primary PCI for STEMI between March 2020 to May 2021. The primary outcome of this study is the access-site complication including major bleeding requiring transfusion or surgery, hematoma and arterial occlusion.

NCT ID: NCT04941482 Completed - Stroke Clinical Trials

Intervention Effectiveness Towards Improving Physical and Mental Health for Post-stroke Patients.

Start date: August 1, 2021
Phase: N/A
Study type: Interventional

This is a multi-intervention randomized controlled trial that aimed to develop a management pattern for stroke survivors. The program consists of monitoring the recovery process, early detecting the physical and mental disorders, suitably intervening for each patient to improve their quality of life. New intervention techniques will be firstly applied for post-stroke patients in Vietnam such as using the portable functional near-infrared spectroscopy (fNIRS) device to explore cortex frontal hemodynamic and motivational interviewing for psychological adjustment. A total of registered 92 stroke patients in Vietnam National Geriatrics Hospital will be included in the study for 6 months. Included patients will be randomized to an intervention group and received the long-term follow-up program or to a control group receiving standard care. The mental health and physical functioning of participants will be assessed at 0, 1, 3, and 6 months follow-up. This work was funded by Vingroup Joint Stock Company and supported by the Domestic Master/Ph.D. Scholarship Programme of Vingroup Innovation Foundation (VINIF), Vingroup Big Data Institute (VINBIGDATA).